Sanofi gets Warp Drive aminoglycosides | Chemical & Engineering News
Volume 94 Issue 48 | p. 15 | Concentrates
Issue Date: December 5, 2016

Sanofi gets Warp Drive aminoglycosides

Department: Business
Keywords: antibiotics, Sanofi, Warp Drive, genome mining

Sanofi has taken in-house an early-stage antibiotics program developed by its partner Warp Drive Bio. The novel aminoglycosides were discovered using Warp Drive’s genome mining technology, which involves searching the sequences of bacteria for gene clusters that encode for analogs of known antibiotics. Sanofi has been an investor in Warp Drive since 2012 and earlier this year agreed to pay up to $750 million for the rights to gram-negative antibiotics and molecules that modulate the oncology target Ras. Sanofi will be responsible for preclinical and clinical research for the aminoglycosides.

 
Chemical & Engineering News
ISSN 0009-2347
Copyright © American Chemical Society

Leave A Comment

*Required to comment